4.5 Article

Preventive Effect of Betaine Against Cognitive Impairments in Amyloid β Peptide-Injected Mice Through Sirtuin1 in Hippocampus

Journal

NEUROCHEMICAL RESEARCH
Volume 47, Issue 8, Pages 2333-2344

Publisher

SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11064-022-03622-z

Keywords

Alzheimer's disease; Betaine; Amyloid beta protein; Sirtuin

Funding

  1. Japan Society for the Promotion of Science (JSPS) [17K08321, 20K07076]
  2. International Research Center for Pathogenesis of Intractable Diseases
  3. Research Institute of Meijo University
  4. MEXT in Japan
  5. Recycle of Natural Resources
  6. Grants-in-Aid for Scientific Research [20K07076, 17K08321] Funding Source: KAKEN

Ask authors/readers for more resources

This study found that betaine can prevent memory impairments caused by Aβ deposition and its mechanism of action involves activating the SIRT1 molecule. These findings provide new insight for the treatment of Alzheimer's disease.
In the pathophysiology of Alzheimer's disease, the deposition of amyloid beta peptide (A beta) is associated with oxidative stress, leading to cognitive impairment and neurodegeneration. We have already reported that betaine (glycine betaine), an osmolyte and methyl donor in cells, prevents the development of cognitive impairment in mice with intracerebroventricular injection of A beta(25-35), an active fragment of A beta, associated with oxidative stress in the hippocampus, but molecular mechanisms of betaine remain to be determined. Here, to investigate a key molecule underlying the preventive effect of betaine against cognitive impairments in A beta(25-35)-injected mice, cognitive tests and qPCR assays were performed in A beta(25-35)-injected mice with continuous betaine intake, in which intake was started a day before A beta(25-35) injection, and then continued for 8 days. The A beta(25-35) injection impaired short-term and object recognition memories in the Y-maze and object recognition tests, respectively. PCR assays revealed the down-regulation of Sirtuin1 (SIRT1), a NAD(+)-dependent deacetylase that mediates metabolic responses, in the hippocampus of A beta(25-35)-injected mice, whereas betaine intake prevented memory deficits as well as the decrease of hippocampal SIRT1 expression in A beta(25-35)-injected mice. Further, sirtinol, an inhibitor of the Sirtuin family, blocked the preventive effect of betaine against memory deficits. On the other hand, resveratrol, the potent compound that activates SIRT1, also prevented memory impairments in A beta(25-35)-injected mice, suggesting that SIRT1 plays a causative role in the preventive effect of betaine against memory deficits caused by A beta exposure.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available